Restart Tablet
Product Images NDC 80584-103

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Restart (NDC 80584-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Winx Health Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0ce2b1db 0b70 4548 E063 6294a90a84f1

0ce2b1db 0b70 4548 E063 6294a90a84f1
A single oral tablet in a clear blister pack for Restart (levonorgestrel) 1.5 mg. The tablet is round and light orange in color. The blister card is transparent with visible indents for packaging the single dose.*
FDA Label Image

Active Ingredients (Active Ingredient)

Active Ingredients (Active Ingredient)
Drug Facts panel showing active ingredient Levonorgestrel 1.5 mg with its purpose listed as emergency contraceptive.*
FDA Label Image

Dose&admin2 (Dosage And Admin)

Dose&admin2 (Dosage And Admin)
Directions text panel instructing to take the medication as soon as possible within 72 hours (3 days) after unprotected sex, with a note to take it sooner for better effectiveness. It advises contacting a healthcare professional if vomiting occurs within 2 hours of taking the medication to determine if the dose should be repeated.*
FDA Label Image

Dose & Admin (Dosage And Admin2)

Dose & Admin (Dosage And Admin2)
Restart Levonorgestrel Tablet 1.5 mg, oral emergency contraceptive, label showing dosage as one tablet taken in one step. Instructions emphasize taking it as soon as possible within 72 hours after unprotected sex for effectiveness. Labeler is Winx Health Inc.*
FDA Label Image

Inactive Ingredients (Inactive Ingredients)

Inactive Ingredients (Inactive Ingredients)
Text panel listing inactive ingredients of Restart levonorgestrel 1.5 mg oral tablet, including colloidal silicon dioxide, FD&C Yellow No. 6 aluminum lake, lactose monohydrate, magnesium stearate, and pregelatinized starch.*
FDA Label Image

No Children (Kids)

No Children (Kids)
Drug facts text panel providing overdose instructions: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center at 1-800-222-1222.*
FDA Label Image

Purpose (Purpose)

Purpose (Purpose)
Drug Facts panel showing the active ingredient Levonorgestrel 1.5 mg listed as an emergency contraceptive. The label provides basic information about the active ingredient and its purpose.*
FDA Label Image

Carton Label (Stix Carton)

Carton Label (Stix Carton)
Packaging label for Restart Morning-After Pill, Levonorgestrel Tablet, 1.5 mg, oral emergency contraceptive by Winx Health Inc. The carton displays directions, warnings, inactive ingredients, and a barcode. The label highlights one tablet per package and states it is not for regular birth control, with a comparison to Plan B's active ingredient.*
FDA Label Image

Usage (Use)

Usage (Use)
A text panel excerpt from Restart (Levonorgestrel) 1.5 mg oral tablet label describing its use. It states the product is for women to reduce the chance of pregnancy after unprotected sex, if a contraceptive failed or if birth control was not used.*
FDA Label Image

Warning Label (Warnings)

Warning Label (Warnings)
A drug facts warnings panel for Restart tablet containing levonorgestrel. It includes allergy alert about allergic reactions, a sexual transmitted diseases alert clarifying the product doesn't protect against HIV/STDs, advice for use if already pregnant or on certain medications, and signs to seek medical help if overdosed. It lists possible side effects such as menstrual changes, headache, dizziness, and more.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.